MODIFICATION
B -- Infusion Pump Market Analysis
- Notice Date
- 4/19/2006
- Notice Type
- Modification
- NAICS
- 541910
— Marketing Research and Public Opinion Polling
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 5630 Fishers Lane, Room 2129, Rockville, MD, 20857-0001
- ZIP Code
- 20857-0001
- Solicitation Number
- R1015991
- Response Due
- 4/25/2006
- Archive Date
- 10/1/2006
- Point of Contact
- Elizabeth Osinski, Contracting Officer , Phone 301-827-7043, Fax 301-827-7101, - Alice Pag?n, Contract Specialist, Phone (301) 827-7104, Fax (301) 827-7101,
- E-Mail Address
-
elizabeth.osinski@fda.hhs.gov, APagan@oc.fda.gov
- Description
- THIS MODIFICATION IS ISSUED TO THE ORIGINAL SYNOPSIS. The original synopsis is also reprinted below. The following amendment is published to the Combined Solicitation No. R1015991: Questions and Responses: 1. The technical evaluation factors listed seem to address deliverables, rather than qualifications. How will a contractor be selected? The evaluation factors for this procurement have been revised as set forth in this amendment. 2. Should enteral feeding pumps be included in the response? Enteral feeding pumps are not part of this requirement. EVALUATION FACTORS FOR AWARD are revised to read as follows: (1) Offeror?s ability to analyze the market share per unit sold by manufacturer and pump type (competitor analysis) (2) Offeror?s ability to analyze the manufacturing capacity of each manufacturer (3) Offeror?s ability to analyze the distribution networks in place for the dissemination of these pumps into the health care system (4) Offeror?s ability to analyze manufacturer throughput time. (5) MANDATORY REQUIREMENT ? The offeror must be able to deliver the Competitor Analysis 3 weeks after this procurement is awarded. (6) Price Offerors in response to this announcement shall address each criterion narratively in detail in their response to this announcement. The technical criteria, items 1 through 5 when combined, are more important than factor (6) price. Quotes will be evaluated on the basis of the technical factors above and price and award will be based on the best value to the government. The Government intends to award one firm-fixed price purchase order resulting from this combined synopsis/solicitation to the responsible, responsive, technically acceptable offeror whose quotation conforming to this combined synopsis/solicitation, will offer the best value to the Government, price and other factors considered. The due date for receipt of quotes remains unchanged, 4/25/2006. Proposals/Quotes shall be submitted electronically to Elizabeth.Osinski@fda.hhs.gov and Alice.Pagan@oc.fda.gov ORIGINAL SYNOPSIS: This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Subpart 12.6, in conjunction with FAR 13.5, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. The solicitation number is R1015991 and is issued as a Request for Quotations. The Government plans to award a purchase order for the analysis of the infusion pump market. The Statement of work is as follows: 1. Analysis of Leading Competitors The offeror must compile total market values and market shares by unit sales for each segment of the infusion pump market. Segments to be analyzed include: ? Insulin Pumps ? Implantable Pumps ? Electronic Ambulatory Pumps ? Disposable Ambulatory Pumps ? Volumetric Pumps ? PCA Volumetric Pumps ? Syringe Pumps 2. The offeror must present a text-based deliverable including unit shares as well as unit share analysis for each segment, as well as for the market as a whole. Analysis will be based on primary and secondary research and will include quantitative depictions of 2005 unit shares in graphical and tabular format accompanied by qualitative analysis. 3. In-Depth Manufacturing and Distribution Analysis Following the delivery of Part A, the offeror must have the ability to delve into the dynamics of the manufacturing and distribution arrangements in the infusion pump market. This analysis will focus on determining all competitors in the US infusion pump market and, in particular, the top 12 manufacturers by overall unit share. For each competitor the offeror will determine: The manufacturing capacity of that manufacturer Distribution networks in place for the dissemination of these pumps into the health care system Manufacturer throughput time Manufacturing and Distribution Analysis needed 8 weeks after this simplified acquisition is awarded 4.The offeror must amalgamate the initial unit share information into a final text-based report. This report needs to be segmented by competitor. A similar analysis is needed for each competitor. In addition, these analyses must be prefaced by an overview chapter, comparing manufacturers. Quarterly Tracking The offeror must also offer the option to repeat this research on a quarterly basis. In this case, the FDA will need 2 quarterly deliverable tracking changes in unit shares and distribution agreements. The following quarterly results will be delivered. ? May 31, 2006 o Current Manufacturing Capacity, as of April 1, 2006 o Current Distribution Network, as of April 1, 2006 o Manufacturer Throughput Time, as of April 1, 2006 ? August 31, 2006 o Current Manufacturing Capacity, as of July 1, 2006 o Current Distribution Network, as of July 1, 2006 o Manufacturer Throughput Time, as of July 1, 2006 Technical Evaluation Criteria are listed below for the infusion pump market. (Insulin Pumps, Implantable Pumps, Electronic Ambulatory Pumps, Disposable Ambulatory Pumps, Volumetric Pumps, PCA Volumetric Pumps and Syringe Pumps) TECHNICAL EVALUATION CRITERIA 1. Market share per unit sold by manufacturer and pump type (competitor analysis) 2. The manufacturing capacity of each manufacturer 3. Distribution networks in place for the dissemination of these pumps into the health care system 4. Manufacturer throughput time 5. Competitor Analysis needed 3 weeks after this procurement is awarded. (Criterion number 5. is a MANDATORY REQUIREMENT. Proposals shall be submitted electronically to Elizabeth.Osinski@fda.hhs.gov and Alice.Pagan@fda.hhs.gov by 4/25/2006. Proposals must be on a fixed price basis. Proposals will be evaluated on the basis of technical and cost factors and award will be based on the best value to the government.
- Place of Performance
- Address: Unknown
- Record
- SN01030850-W 20060421/060419220354 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |